Transcriptomics age acceleration in prolonged treated HIV infection

Flora Mikaeloff*, Marco Gelpi, Alejandra Escos, Andreas D. Knudsen, Julie Høgh, Thomas Benfield, João Pedro de Magalhães, Susanne D. Nielsen, Ujjwal Neogi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

38 Downloads (Pure)

Abstract

Biological aging in people with HIV (PWH) with prolonged successful antiretroviral therapy (ART) is convoluted and poorly defined. Here, we aimed to investigate the transcriptomics age estimator (TAE) in a cohort of 178 PWH on prolonged successful ART with immune reconstitution and viral suppression from the Copenhagen Comorbidity (COCOMO) cohort. We also used 143 clinical, demographical, and lifestyle factors to identify the confounders potentially responsible or associated with age acceleration. Among the PWH, 43% had an accelerated aging process (AAP), and 21% had decelerated aging process (DAP). DAP is linked with older age, European ancestry, and higher use of tenofovir disoproxil/alafenamide fumarate. A directionally class‐based gene set enrichment analysis identified the upregulation of inflammatory pathways (e.g., cytokine and Retinoic acid‐inducible gene I (RIG‐I)‐like receptor signaling pathways) and immune response like T‐cell receptor signaling, antigen processing, and presentation in AAP and the downregulation of metabolic processes like oxidative phosphorylation, pyruvate metabolism.
Original languageEnglish
Article numbere13951
JournalAging Cell
Early online date7 Aug 2023
DOIs
Publication statusE-pub ahead of print - 7 Aug 2023

Keywords

  • biological aging
  • treated HIV infection
  • transcriptomics aging clock

Fingerprint

Dive into the research topics of 'Transcriptomics age acceleration in prolonged treated HIV infection'. Together they form a unique fingerprint.

Cite this